Using Dose Titration to Resolve Acne on Testosterone Cypionate

What the cypionate label says about acne and dose

Depo-Testosterone's adverse reactions section lists acne in a short skin list alongside hirsutism, male pattern baldness and seborrhea, with no frequency attached [1]. The dosage section says the suggested dose varies with age, sex and diagnosis, that dosage is adjusted according to the patient's response and the appearance of adverse reactions, and that replacement dosing runs from 50 to 400 mg every 2 to 4 weeks [1].

Two variables sit inside the label: the amount, 50 to 400 mg, and the interval, 2 to 4 weeks [1]. The label gives no acne-specific step size and no expected time for skin to improve after a dose change, and it does not identify a serum testosterone level at which acne does or does not occur [1].

HealthRX.com offers testosterone cypionate by prescription.

How often does acne happen on testosterone?

A 2017 review in Lancet Diabetes & Endocrinology of testosterone therapy for transgender men lists acne among the undesired effects, alongside alopecia, reduced HDL cholesterol, increased triglycerides and a possible rise in systolic blood pressure [2]. That review covers a different treated population, men aiming for a male reference range rather than men treated for hypogonadism, so it confirms acne as a recognized effect of testosterone therapy rather than supplying a rate.

Injection timing and the label

Testosterone esters in oil are absorbed slowly from the lipid phase, which is why testosterone cypionate can be given at intervals of two to four weeks; the label gives a half-life of about 8 days after an intramuscular injection [1]. The label does not say whether changing the injection interval improves acne [1].

What else gets checked when the dose changes

A dose change is also a checkpoint. The 2018 Endocrine Society guideline recommends monitoring symptoms, serum testosterone, hematocrit and prostate cancer risk during the first year of therapy [3]. The cypionate label says to check hemoglobin and hematocrit periodically during long-term use and to monitor blood pressure periodically, especially in men with hypertension [1].

A review of 29 placebo-controlled trials involving 3,393 men compared several testosterone formulations. In its pooled estimate, intramuscular enanthate or cypionate raised mean hematocrit by 4.0% versus placebo [4].

Treating the acne itself

A 2021 editorial in the Journal of Drugs in Dermatology on isotretinoin prescribing for transgender patients opens with a 26-year-old on weekly intramuscular testosterone with severe nodulocystic scarring acne [7]. It is a call for guidance rather than an outcomes study, and it does not report what happened when isotretinoin was combined with a testosterone dose change.